U.S. Markets open in 2 mins
S&P Futures
3,329.25-15.00(-0.45%)Dow Futures
27,198.00-87.00(-0.32%)Nasdaq Futures
11,219.25-42.00(-0.37%)
Inventiva S.A. (IVA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.36+0.69 (+6.47%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 10.67 |
| Open | 11.13 |
| Bid | 11.13 x 3200 |
| Ask | 11.38 x 1200 |
| Day's Range | 10.95 - 11.36 |
| 52 Week Range | 9.01 - 15.95 |
| Volume | 86,458 |
| Avg. Volume | 291,675 |
| Market Cap | 423.755M |
| Beta (5Y Monthly) | 1.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Barrons.com
13Ds Filings
Activist reports to the SEC from July 16 through July 22, 2020, including positions in Anterix, Inventiva, BeiGene, and two other companies
- GlobeNewswire
Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global Market
Daix (France), July 15, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral.
- GlobeNewswire
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the.
© 2020 Verizon Media. All rights reserved.
